S&P 500

5.661,42

0,54%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
ICON PLC (ICLR)
ICON PLC (ICLR) Notícias

ICLR

ICON (ICLR)

ICON PLC

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ICLR

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
16/02/2016	09:07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ICLR	ICON PLC
09/02/2016	16:21	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ICLR	ICON PLC
09/02/2016	08:00	Business Wire	ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases	NASDAQ:ICLR	ICON PLC
12/01/2016	09:07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:ICLR	ICON PLC
05/01/2016	09:00	Business Wire	ICON Secures Investment Grade Credit Ratings	NASDAQ:ICLR	ICON PLC
16/12/2015	09:00	Business Wire	ICON plc Announces Private Placement of US$350,000,000 of Senior Notes	NASDAQ:ICLR	ICON PLC
07/12/2015	11:30	Business Wire	ICON Acquires PMG Research, Inc.	NASDAQ:ICLR	ICON PLC
25/11/2015	09:00	Business Wire	ICON Announces the Appointment of Dr. Steve Cutler to Board of Directors	NASDAQ:ICLR	ICON PLC
27/10/2015	08:00	Business Wire	ICON Reports Third Quarter 2015	NASDAQ:ICLR	ICON PLC
10/09/2015	09:01	Business Wire	ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up Timelines	NASDAQ:ICLR	ICON PLC
05/08/2015	10:15	PR Newswire (US)	Financial Performance Review - Report on ICON	NASDAQ:ICLR	ICON PLC
28/07/2015	07:00	Business Wire	ICON Reports Second Quarter 2015	NASDAQ:ICLR	ICON PLC
27/07/2015	07:00	Business Wire	ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting	NASDAQ:ICLR	ICON PLC
17/07/2015	10:20	PR Newswire (US)	Medical Laboratories and Research Equities Technical Momentum -- Agilent Technologies, Organovo Holdings, Biocept, Novadaq Te...	NASDAQ:ICLR	ICON PLC
17/06/2015	12:00	Business Wire	ICON Launches Firecrest Patient Portal to Enhance Education around Informed Consent	NASDAQ:ICLR	ICON PLC
14/05/2015	16:05	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ICLR	ICON PLC
30/04/2015	15:34	Analyst Ratings Network	Icon Plc Stock Rating Upgraded by Zacks (ICLR)	NASDAQ:ICLR	ICON PLC
28/04/2015	07:00	Business Wire	ICON Reports First Quarter 2015	NASDAQ:ICLR	ICON PLC
24/04/2015	11:28	Analyst Ratings Network	Icon Plc PT Raised to $70.00 (ICLR)	NASDAQ:ICLR	ICON PLC
23/04/2015	12:30	Business Wire	ICON Launches Electronic Informed Consent	NASDAQ:ICLR	ICON PLC
13/04/2015	08:30	Business Wire	New Book by Industry Thought Leaders Advocates for Re-Engineering Clinical Trials	NASDAQ:ICLR	ICON PLC
23/03/2015	09:00	Business Wire	ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent Processes	NASDAQ:ICLR	ICON PLC
12/03/2015	18:06	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:ICLR	ICON PLC
09/03/2015	08:30	Business Wire	ICON Launches Medical Device & Diagnostics Research Group	NASDAQ:ICLR	ICON PLC
02/03/2015	08:00	Business Wire	ICON Completes Acquisition of MediMedia Pharma Solutions	NASDAQ:ICLR	ICON PLC
25/02/2015	08:00	Business Wire	ICON Reports Fourth Quarter and Full Year 2014 Results and Issues 2015 Earnings Guidance	NASDAQ:ICLR	ICON PLC
02/02/2015	09:00	Business Wire	ICON to Acquire MediMedia Pharma Solutions	NASDAQ:ICLR	ICON PLC
06/11/2014	09:11	Business Wire	ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials	NASDAQ:ICLR	ICON PLC
22/10/2014	08:00	Business Wire	ICON Reports Third Quarter 2014 and Increases Earnings Guidance	NASDAQ:ICLR	ICON PLC
19/09/2014	07:00	Business Wire	ICON Plc Announces Completion of $40 Million Share Buyback and a Further Share Buyback Program for up to $100 Million	NASDAQ:ICLR	ICON PLC